Matrivax Research & Development Corp.
Matrivax is developing a new, inexpensive technology to bring vaccines for infectious bacteria to the developing world. The vaccines can prevent diseases caused by infectious bacteria, such as penumococcus, haemophilus and menigococcus, which affect young children and the elderly. Conjugate vaccines have begun to address this problem but are not readily available in the developing world due to their cost. Initially, we will focus on the development of a vaccine for Streptococcus pneumoniae. We are working closely with Vaccine Technologies, Inc. to utilize their expertise in establishing research and manufacturing facilities in China.Back to list